4
Changes in Ownership
Drugs Made In America Acquisition II Corp. Filed Acc 0001213900-25-094436
CEO and Exe. Chair of Board bought 700,000 shares
- CEO and Exe. Chair of Board sold 7,966,667 shares
- CEO and Exe. Chair of Board disposed of 400,000 shares (other)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Stockwell Lynn CEO and Exe. Chair of Board | 2025-09-26 | Purchase | +700,000 | 15,075,000 | I | ||
| Stockwell Lynn CEO and Exe. Chair of Board | 2025-09-26 | Other disposition | −400,000 | 14,675,000 | I | ||
| Stockwell Lynn CEO and Exe. Chair of Board | 2025-09-26 | Sale | −7,966,667 | 6,708,333 | I | ||
| Derivatives | |||||||
| Stockwell Lynn CEO and Exe. Chair of Board | 2025-09-26 | Purchase · Rights to receive ordinary shares | +700,000 | 700,000 | I | ||
| Open-market purchases · 700,000 sh | |||||||
| Open-market sales · 7,966,667 sh | |||||||
Loading xslF345X05/ownership.xml…